Promotor Methylation in Ocular Surface Squamous Neoplasia Development: Epigenetics Implications in Molecular Diagnosis Publisher Pubmed



Shahraki K^{1, 2} ; Shahraki K^{1, 2} ; Ghasemi Boroumand P⁴ ; Sheervalilou R⁵ Show Affiliations
Source: Expert Review of Molecular Diagnostics Published:2023

Abstract

Introduction: Cancer is heavily influenced by epigenetic mechanisms that include DNA methylation, histone modifications, and non-coding RNA. A considerable proportion of human malignancies are believed to be associated with global DNA hypomethylation, with localized hypermethylation at promoters of certain genes. Area covered: The present review aims to emphasize on recent investigations on the epigenetic landscape of ocular surface squamous neoplasia, that could be targeted/explored using novel approaches such as personalized medicine. Expert opinion: While the former is thought to contribute to genomic instability, promoter-specific hypermethylation might facilitate tumorigenesis by silencing tumor suppressor genes. Ocular surface squamous neoplasia, the most prevalent type of ocular surface malignancy, is suggested to be affected by epigenetic mechanisms, as well. Although the exact role of epigenetics in ocular surface squamous neoplasia has mostly been unexplored, recent findings have greatly contributed to our understanding regarding this pathology of the eye. © 2023 Informa UK Limited, trading as Taylor & Francis Group.